Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179824 | SCV000232138 | benign | not specified | 2015-06-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000179824 | SCV000306904 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000179824 | SCV000519343 | benign | not specified | 2016-01-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000576703 | SCV000677294 | benign | X-linked myopathy with postural muscle atrophy; X-linked scapuloperoneal muscular dystrophy | 2017-05-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000179824 | SCV001623251 | benign | not specified | 2021-04-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001514139 | SCV001721894 | benign | X-linked myopathy with postural muscle atrophy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001701699 | SCV001933449 | benign | Uruguay Faciocardiomusculoskeletal syndrome | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001514139 | SCV001933450 | benign | X-linked myopathy with postural muscle atrophy | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001701631 | SCV001933451 | benign | Myopathy, reducing body, X-linked, early-onset, severe | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001701630 | SCV001933453 | benign | Myopathy, reducing body, X-linked, childhood-onset | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001701782 | SCV001933454 | benign | X-linked scapuloperoneal muscular dystrophy | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004713402 | SCV005279587 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000179824 | SCV001741531 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000179824 | SCV001919815 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000179824 | SCV001927473 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000179824 | SCV001970497 | benign | not specified | no assertion criteria provided | clinical testing |